A detailed history of Mariner, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Mariner, LLC holds 346,679 shares of NVO stock, worth $35.3 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
346,679
Previous 343,357 0.97%
Holding current value
$35.3 Million
Previous $49 Million 15.77%
% of portfolio
0.07%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $395,550 - $483,085
3,322 Added 0.97%
346,679 $41.3 Million
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $3.56 Million - $4.26 Million
28,989 Added 9.22%
343,357 $49 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $1.76 Million - $2.34 Million
17,245 Added 5.8%
314,368 $40.4 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $1.32 Million - $1.58 Million
15,014 Added 5.32%
297,123 $30.7 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $14.1 Million - $30.8 Million
154,587 Added 121.22%
282,109 $25.7 Million
Q2 2023

Aug 11, 2023

SELL
$155.98 - $172.65 $290,122 - $321,129
-1,860 Reduced 1.44%
127,522 $20.6 Million
Q1 2023

May 12, 2023

SELL
$132.34 - $159.14 $788,614 - $948,315
-5,959 Reduced 4.4%
129,382 $20.6 Million
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $339,030 - $447,400
3,306 Added 2.5%
135,341 $18.3 Million
Q3 2022

Nov 10, 2022

BUY
$95.28 - $116.93 $3.18 Million - $3.9 Million
33,325 Added 33.76%
132,035 $13.2 Million
Q2 2022

Aug 15, 2022

SELL
$103.24 - $121.81 $1.52 Million - $1.79 Million
-14,676 Reduced 12.94%
98,710 $11 Million
Q1 2022

May 13, 2022

BUY
$93.1 - $112.54 $286,003 - $345,722
3,072 Added 2.78%
113,386 $12.6 Million
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $3.89 Million - $4.75 Million
40,563 Added 58.15%
110,314 $12.4 Million
Q3 2021

Nov 15, 2021

SELL
$84.42 - $106.62 $667,255 - $842,724
-7,904 Reduced 10.18%
69,751 $6.7 Million
Q2 2021

Aug 24, 2021

SELL
$67.66 - $84.76 $13,193 - $16,528
-195 Reduced 0.25%
77,655 $6.51 Million
Q1 2021

May 07, 2021

SELL
$67.06 - $75.82 $557,670 - $630,519
-8,316 Reduced 9.65%
77,850 $5.25 Million
Q4 2020

Feb 16, 2021

BUY
$63.89 - $73.8 $2.16 Million - $2.5 Million
33,863 Added 64.74%
86,166 $6.02 Million
Q3 2020

Nov 13, 2020

BUY
$63.69 - $70.22 $34,838 - $38,410
547 Added 1.06%
52,303 $3.63 Million
Q2 2020

Aug 14, 2020

BUY
$58.54 - $67.94 $548,988 - $637,141
9,378 Added 22.13%
51,756 $3.39 Million
Q1 2020

May 14, 2020

BUY
$49.46 - $64.78 $237,457 - $311,008
4,801 Added 12.78%
42,378 $2.55 Million
Q4 2019

Feb 13, 2020

BUY
$49.86 - $58.26 $44,674 - $52,200
896 Added 2.44%
37,577 $2.18 Million
Q3 2019

Nov 13, 2019

BUY
$47.54 - $53.43 $70,929 - $79,717
1,492 Added 4.24%
36,681 $1.9 Million
Q2 2019

Aug 14, 2019

BUY
$46.79 - $52.47 $66,488 - $74,559
1,421 Added 4.21%
35,189 $1.8 Million
Q1 2019

May 15, 2019

BUY
$46.36 - $52.63 $51,366 - $58,314
1,108 Added 3.39%
33,768 $1.77 Million
Q4 2018

Feb 13, 2019

BUY
$41.54 - $47.25 $138,826 - $157,909
3,342 Added 11.4%
32,660 $1.51 Million
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $3,366 - $3,689
72 Added 0.25%
29,318 $1.38 Million
Q2 2018

Aug 14, 2018

BUY
$44.29 - $50.42 $520,230 - $592,233
11,746 Added 67.12%
29,246 $1.35 Million
Q1 2018

May 15, 2018

SELL
$48.49 - $58.14 $700,632 - $840,064
-14,449 Reduced 45.23%
17,500 $862,000
Q4 2017

Feb 09, 2018

SELL
$47.53 - $53.73 $31,274 - $35,354
-658 Reduced 2.02%
31,949 $1.71 Million
Q3 2017

Nov 14, 2017

BUY
$41.15 - $49.22 $1.34 Million - $1.6 Million
32,607
32,607 $1.57 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.